• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接种疫苗人数不断增加的情况下,根据 RSNA 共识指南,胸部 CT 显示 COVID-19 典型表现的真阳性发现率。

Rate of True-Positive Findings of COVID-19 Typical Appearance at Chest CT per RSNA Consensus Guidelines in an Increasingly Vaccinated Population.

机构信息

From the Department of Scholarly Engagement, Harvard Medical School, 25 Shattuck St, Boston, MA 02115 (N.J.P., E.J.F.); Department of Radiology, Massachusetts General Hospital, Boston, Mass (A.S., N.D.M., J.D.C., E.J.F.); and Department of Radiology, Mayo Clinic Florida, Jacksonville, Fla (B.P.L.).

出版信息

Radiology. 2023 Mar;306(3):e220680. doi: 10.1148/radiol.220680. Epub 2022 Sep 6.

DOI:10.1148/radiol.220680
PMID:36066367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9462593/
Abstract

Background RSNA consensus guidelines for COVID-19-related chest CT are widely used but, to the knowledge of the authors, their rate of true-positive findings for COVID-19 pneumonia in vaccinated patients has not been assessed. Purpose To assess the rate of true-positive findings of typical appearance for COVID-19 at chest CT by using RSNA guidelines in fully vaccinated patients with polymerase chain reaction (PCR)-confirmed COVID-19 infection compared with unvaccinated patients. Materials and Methods Included were patients with COVID-19 who had typical appearance on chest CT images and one PCR test for COVID-19 with a positive result or two tests with negative results within 7 days of undergoing chest CT between January 2021 and January 2022 at a quaternary academic medical center. True-positive findings were defined as chest CT images interpreted as COVID-19 typical appearance and PCR-confirmed COVID-19 infection within 7 days. Logistic regression models were constructed to quantify the association between PCR results and vaccination status, vaccination status and COVID-19 variants, and vaccination status and number of months. Results Included were 652 patients (median age, 59 years; IQR, 48-72 years; 371 men [57%]) with CT scans classified as typical appearance. Of those patients, 483 (74%) were unvaccinated and 169 (26%) were fully vaccinated. The overall rate of true-positive findings on CT images rated as typical appearance was lower in vaccinated versus unvaccinated patients (70 of 169 [41%; 95% CI: 34, 49] vs 352 of 483 [73%; 95% CI: 69, 77]; odds ratio [OR], 3.8 [95% CI: 2.6, 5.5]; < .001). Unvaccinated patients were more likely to have true-positive findings on CT images compared with fully vaccinated patients during the peaks of COVID-19 variants Alpha (OR, 16; 95% CI: 6, 42; < .001) and Delta (OR, 8; 95% CI: 4, 16; < .001), but no statistical differences were found during the peak of the Omicron variant (OR, 1.7; 95% CI: 0.3, 11; = .56). Conclusion Fully vaccinated patients with confirmed COVID-19 breakthrough infections had lower rates of true-positive findings of COVID-19 typical appearance at chest CT. © RSNA, 2022 .

摘要

背景

RSNA 关于 COVID-19 相关胸部 CT 的共识指南被广泛应用,但据作者所知,其在接种疫苗患者中 COVID-19 肺炎的真阳性发现率尚未得到评估。目的:在聚合酶链反应(PCR)确诊的 COVID-19 感染的完全接种疫苗患者中,使用 RSNA 指南评估 COVID-19 胸部 CT 上典型表现的真阳性发现率,并与未接种疫苗患者进行比较。材料与方法:纳入 2021 年 1 月至 2022 年 1 月在一家四级学术医疗中心接受胸部 CT 检查的 COVID-19 患者,这些患者的胸部 CT 图像有典型表现,且至少有一次 PCR 检测结果为 COVID-19 阳性,或两次检测结果为 COVID-19 阴性,但两次检测时间间隔在 7 天内。真阳性发现定义为在 7 天内 CT 图像被解读为 COVID-19 典型表现且 PCR 确诊 COVID-19 感染。构建逻辑回归模型来量化 PCR 结果与接种状态、接种状态与 COVID-19 变异体、以及接种状态与月数之间的关联。结果:共纳入 652 例(中位年龄 59 岁;IQR:48-72 岁;371 例男性[57%])患者的 CT 扫描结果为典型表现。其中 483 例(74%)未接种疫苗,169 例(26%)完全接种疫苗。与未接种疫苗的患者相比,接种疫苗的患者 CT 图像上典型表现的真阳性发现率较低(70/169[41%],95%CI:34,49,与 352/483[73%],95%CI:69,77;比值比[OR],3.8[95%CI:2.6,5.5];<0.001)。在 COVID-19 Alpha(OR,16;95%CI:6,42;<0.001)和 Delta(OR,8;95%CI:4,16;<0.001)变异体高峰期,未接种疫苗的患者更有可能在 CT 图像上出现真阳性发现,但在 Omicron 变异体高峰期未发现统计学差异(OR,1.7;95%CI:0.3,11;=0.56)。结论:在确诊为 COVID-19 突破性感染的完全接种疫苗患者中,COVID-19 胸部 CT 上典型表现的真阳性发现率较低。©RSNA,2022。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705d/9968767/7b72c4b04c00/radiol.220680.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705d/9968767/aaad2746f0be/radiol.220680.VA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705d/9968767/2137ca8cfbed/radiol.220680.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705d/9968767/840027f22c06/radiol.220680.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705d/9968767/7b72c4b04c00/radiol.220680.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705d/9968767/aaad2746f0be/radiol.220680.VA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705d/9968767/2137ca8cfbed/radiol.220680.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705d/9968767/840027f22c06/radiol.220680.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705d/9968767/7b72c4b04c00/radiol.220680.fig3.jpg

相似文献

1
Rate of True-Positive Findings of COVID-19 Typical Appearance at Chest CT per RSNA Consensus Guidelines in an Increasingly Vaccinated Population.在接种疫苗人数不断增加的情况下,根据 RSNA 共识指南,胸部 CT 显示 COVID-19 典型表现的真阳性发现率。
Radiology. 2023 Mar;306(3):e220680. doi: 10.1148/radiol.220680. Epub 2022 Sep 6.
2
Reduction in Chest CT Severity and Improved Hospital Outcomes in SARS-CoV-2 Omicron Compared with Delta Variant Infection.与德尔塔变异株感染相比,奥密克戎变异株感染导致胸部 CT 严重程度降低和住院结局改善。
Radiology. 2023 Jan;306(1):261-269. doi: 10.1148/radiol.220533. Epub 2022 Jun 21.
3
Impact of Vaccination and the Omicron Variant on COVID-19-related Chest CT Findings: A Multicenter Study.疫苗接种和奥密克戎变异株对 COVID-19 相关胸部 CT 表现的影响:一项多中心研究。
Radiology. 2023 May;307(3):e222730. doi: 10.1148/radiol.222730. Epub 2023 Mar 7.
4
Chest CT Findings in Hospitalized Patients with SARS-CoV-2: Delta versus Omicron Variants.住院 SARS-CoV-2 感染患者的胸部 CT 表现:Delta 变异株与奥密克戎变异株。
Radiology. 2023 Jan;306(1):252-260. doi: 10.1148/radiol.220676. Epub 2022 Jun 28.
5
Imaging and Clinical Features of COVID-19 Breakthrough Infections: A Multicenter Study.COVID-19 突破性感染的影像学和临床特征:一项多中心研究。
Radiology. 2022 Jun;303(3):682-692. doi: 10.1148/radiol.213072. Epub 2022 Feb 1.
6
Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients.灭活新冠病毒疫苗对 B.1.617.2(德尔塔)变异株感染患者肺损伤的影响。
Ann Clin Microbiol Antimicrob. 2023 Mar 21;22(1):22. doi: 10.1186/s12941-023-00569-z.
7
Thoracic imaging tests for the diagnosis of COVID-19.用于诊断新型冠状病毒肺炎的胸部影像学检查
Cochrane Database Syst Rev. 2020 Sep 30;9:CD013639. doi: 10.1002/14651858.CD013639.pub2.
8
Performance of Chest Computed Tomography in Differentiating Coronavirus Disease 2019 From Other Viral Infections Using a Standardized Classification.基于标准化分类的胸部计算机断层扫描对 2019 年冠状病毒病与其他病毒感染的鉴别诊断性能。
J Thorac Imaging. 2021 Jan;36(1):31-36. doi: 10.1097/RTI.0000000000000563.
9
Chest CT in the Emergency Department for Diagnosis of COVID-19 Pneumonia: Dutch Experience.急诊科胸部 CT 诊断 COVID-19 肺炎:荷兰经验。
Radiology. 2021 Feb;298(2):E98-E106. doi: 10.1148/radiol.2020203465. Epub 2020 Nov 17.
10
Chest CT features of COVID-19 in vaccinated versus unvaccinated patients: use of CT severity score and outcome analysis.接种疫苗与未接种疫苗患者 COVID-19 的胸部 CT 特征:使用 CT 严重程度评分和结局分析。
Radiol Med. 2023 Aug;128(8):934-943. doi: 10.1007/s11547-023-01664-z. Epub 2023 Jun 24.

引用本文的文献

1
Evaluating the Accuracy of Chest CT in Detecting COVID-19 Through Tracheobronchial Wall Thickness: Insights From Emergency Department Patients in Mid-2023.通过气管支气管壁厚度评估胸部CT检测2023年年中急诊科患者新型冠状病毒肺炎的准确性:见解
Cureus. 2024 Sep 11;16(9):e69161. doi: 10.7759/cureus.69161. eCollection 2024 Sep.
2
Time-dependent CT score-based model for identifying severe/critical COVID-19 at a fever clinic after the emergence of Omicron variant.基于时间依赖性CT评分的模型,用于在奥密克戎变异株出现后在发热门诊识别重症/危重症新冠肺炎
Heliyon. 2024 Mar 25;10(7):e27963. doi: 10.1016/j.heliyon.2024.e27963. eCollection 2024 Apr 15.
3

本文引用的文献

1
Reduction in Chest CT Severity and Improved Hospital Outcomes in SARS-CoV-2 Omicron Compared with Delta Variant Infection.与德尔塔变异株感染相比,奥密克戎变异株感染导致胸部 CT 严重程度降低和住院结局改善。
Radiology. 2023 Jan;306(1):261-269. doi: 10.1148/radiol.220533. Epub 2022 Jun 21.
2
Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.NBA 高度接种疫苗的球员和工作人员队列中 COVID-19 加强针接种与奥密克戎感染的关联。
JAMA. 2022 Jul 12;328(2):209-211. doi: 10.1001/jama.2022.9479.
3
Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron.
Diagnostic performance of standardized typical CT findings for COVID-19: a systematic review and meta-analysis.
COVID-19标准化典型CT表现的诊断性能:一项系统评价和荟萃分析
Insights Imaging. 2023 May 24;14(1):96. doi: 10.1186/s13244-023-01429-2.
4
Pulmonary computed tomographic manifestations of COVID-19 in vaccinated and non-vaccinated patients.接种疫苗和未接种疫苗患者的 COVID-19 肺部计算机断层扫描表现。
Sci Rep. 2023 Apr 27;13(1):6884. doi: 10.1038/s41598-023-33942-1.
5
Chronic Pulmonary Manifestations of COVID-19 Infection: Imaging Evaluation.COVID-19 感染的慢性肺部表现:影像学评估。
Radiology. 2023 Apr;307(2):e222379. doi: 10.1148/radiol.222379. Epub 2023 Jan 24.
6
Variants and Vaccination of COVID-19: New Complexities for Chest Imaging Research and Clinical Practice.新型冠状病毒肺炎的变异与疫苗接种:胸部影像研究及临床实践面临的新复杂性
Radiology. 2023 Mar;306(3):e222478. doi: 10.1148/radiol.222478. Epub 2022 Oct 18.
同源和异源新冠病毒加强针针对奥密克戎毒株的有效性
N Engl J Med. 2022 Jun 23;386(25):2433-2435. doi: 10.1056/NEJMc2203165. Epub 2022 May 25.
4
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.Covid-19 疫苗对奥密克戎(B.1.1.529)变异株的有效性。
N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2.
5
Imaging and Clinical Features of COVID-19 Breakthrough Infections: A Multicenter Study.COVID-19 突破性感染的影像学和临床特征:一项多中心研究。
Radiology. 2022 Jun;303(3):682-692. doi: 10.1148/radiol.213072. Epub 2022 Feb 1.
6
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.在德尔塔和奥密克戎变异株流行期间,mRNA 疫苗加强针在成年人中的 COVID-19 相关急诊和紧急护理就诊和住院方面的效果 - VISION 网络,10 个州,2021 年 8 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145. doi: 10.15585/mmwr.mm7104e3.
7
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
8
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines.新冠病毒疫苗对轻症和重症疾病的保护持续时间。
N Engl J Med. 2022 Jan 27;386(4):340-350. doi: 10.1056/NEJMoa2115481. Epub 2022 Jan 12.
9
Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina.北卡罗来纳州 9 个月期间的新冠疫苗有效性。
N Engl J Med. 2022 Mar 10;386(10):933-941. doi: 10.1056/NEJMoa2117128. Epub 2022 Jan 12.
10
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.新冠疫苗接种对阿尔法和德尔塔变异株传播的影响。
N Engl J Med. 2022 Feb 24;386(8):744-756. doi: 10.1056/NEJMoa2116597. Epub 2022 Jan 5.